Chronic kidney disease in the type 2 diabetic patients: Prevalence and associated variables in a random sample of 2642 patients of a Mediterranean area

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Coll De Tuero, Gabriel ^a   Mata Cases, Manel ^b   Rodriguez Poncelas, Antonio ^c   Pepió, Josep M A ^d   Roura, Pilar ^e   Benito, Belen ^b   Franch Nadal, Josep ^f   Saez, Marc ^a  

^a UNIVERSITY OF GIRONA   (Spain)

^b INSTITUT CATALÀ DE LA SALUT   (Spain)

^c Research Unit   (Spain)

^d Primary Healthcare Center Tortosa Oest   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f Primary Healthcare Center   (Spain)

Author keywords

Albuminuria; Diabetic nephropathy; Kidney disease; Renal impairment

Indexed keywords

ALBUMIN; CHOLESTEROL; INSULIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIMARY MEDICAL CARE; SOUTHERN EUROPE; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; FOLLOW UP; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; VERY ELDERLY; CHRONIC KIDNEY FAILURE; CONTROLLED CLINICAL TRIAL;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDITERRANEAN REGION; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES;

EID: 84865059115     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-87     Document Type: Article

References (37)

1. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. National Kidney Foundation, Am J Kidney Dis 2002 39 46 64 10.1053/ajkd.2002.31813
2. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Keith DS Nichols GA, Gullion CM Brown JB, Smith DH, Arch Intern Med 2004 164 659 663 10.1001/archinte.164.6.659 15037495
3. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, Kidney Int. 2003 63 225 32 10.1046/j.1523-1755. 2003.00712.x 12472787
4. All-cause and cardiovascular mortality in diabetic subjects increases significantly with reduced estimated glomerular filtration rate (eGFR): 10 years' data from the South Tees Diabetes Mortality study. Nag S, Bilous R, Kelly W, Jones S, Roper N, Connolly V, Diabet Med. 2007 24 10 7 10.1111/j.1464-5491. 2007.02023.x 17227319
5. HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S, JAMA 2001 286 421 6 10.1001/jama.286.4.421 11466120
6. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. Kramer HJ, Nguyen QD, Curhan G, Hsu CY, JAMA. 2003 289 3273 7 10.1001/jama.289.24.3273 12824208
7. Impairment in Glomerular Filtration Rate or Glomerular Filtration Barrier and Occurrence of Stroke. Ovbiagele B, Arch Neurol 2008 65 934 938 10.1001/archneur.65.7.934 18625861
8. Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, J Am Soc Nephrol 2009 20 1813 1821 10.1681/ASN.2008121270 19443635
9. Diabetes 2006. Risk Factors for Renal Dysfunction in Type 2 Diabetes U.K. Prospective Diabetes Study 74. Retnakavan R, Cull CA, Thorne KI, Adler AI, Holman RR, Diabetes 2006 55 1832 1839 10.2337/db05-1620 16731850
10. Strippoli GFM, Craig M, Deeks JJ, Schena FP, Craig JC, Effects of angiotensin converting enzyme inhibitors and angiotensin II receptors antagonist on mortality and renal outcomes in diabetic nephropathy: systematic review
11. Prevalence of hidden renal failure in the population suffering from type-2 diabetes. Tranche Iparraguirre S, Riesgo García A, Marín Iranzo R, Díaz González G, García Fernández A, Aten Primaria 2005 35 359 10.1157/13074294 15871797
12. Prevalence of occult chronic kidney disease and associated variables in a population of patients with type 2 diabetes. Rodríguez-Poncelas A, Quesada Sabate M, Coll De Tuero G, Caula Ros J, Gelada-Batlle E, Gómez-Marcos MA, et al. Med Clin (Barc) 2010 134 239 245 10.1016/j.medcli.2009.06.069
13. Prevalence of chronic kidney disease in patients with type 2 diabetes mellitus treated in primary care. Lou Arnal LM, Campos Gutiérrez B, Cuberes Izquierdo M, Gracia García O, Turón Alcaine JM, Bielsa García S, et al. Nefrologia 2010 30 552 6 20882094
14. Prevalence of low glomerular filtration rate in the elderly population of Spain. Cea-Calvo L, Redon J, Martí-Canales JC, Lozano JV, Llisterri JL, Fernández-Pérez C, The PREV-ICTUS study. Med Clin (Barc) 2007 129 681 7
15. al. Fifteen years of continuous improvement of quality care of type 2 diabetes mellitus in primary care in Catalonia, Spain. Mata-Cases M, Roura-Olmeda P, Berengué-Iglesias M, Birulés-Pons M, Mundet-Tuduri X, Franch-Nadal J, Int J Clin Pract. 2012 66 3 289 98 10.1111/j.1742-1241.2011. 02872.x 22340449
16. An adaptation of the Framingham coronary risk function to southern Europe Mediterranean areas. Marrugat J, D'Agostino R, Sullivan L, Elosua R, Wilson P, Ordovas J, et al. J Epidemiol Comm Health 2003 57 634 8 10.1136/jech.57.8.634
17. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation: Modification of Diet in renal Disease Study Group. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth DN, Ann Intern Med. 1999 30 461 70
18. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease, 2012 http://www.kidney.org/ professionals/KDOQI/guideline-diabetes/guide1.htm (accessed June,2012)
19. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU, Kidney Int. 2011 80 17 28 10.1038/ki.2010.483 21150873
20. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Mancia G, de Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. J Hypertens. 2007 25 1105 1187 10.1097/HJH.0b013e3281fc975a 17563527
21. Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS). Jia W, Gao X, Pang C, Hou X, Bao Y, Liu W, et al. Nephrol Dial Transplant. 2009 24 3724 31 10.1093/ndt/gfp349 19617258
22. Nonalbuminuric renal insufficiency in type 2 diabetes. MacIsaac RJ, Tsalamandris C, Panagiotopoulos S, Smith TJ, McNeil KJ, Jerums G, Diabetes Care. 2004 27 195 200 10.2337/diacare.27.1.195 14693989
23. High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data. Wall BM, Hardison RM, Molitch ME, Marroquin OC, McGill JB, August PA, Am J Med Sci. 2010 339 401 10 20375690
24. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, Nephrol Dial Transplant. 2009 24 1212 9 18984626
25. The unrecognized prevalence of chronic kidney disease in diabetes. Middleton RJ, Foley RN, Hegarty J, Cheung CM, McElduff P, Gibson JM, et al. Nephrol Dial Transplant. 2006 21 88 92 10.1093/ndt/gfi163 16221715
26. Management of hypertension and screening of renal complications by GPs in diabetic type 2 patients (France-2001). Fagnani F, Souchet T, Labed D, Gaugris S, Hannedouche T, Grimaldi A, Diabetes Metab. 2003 29 58 64 10.1016/S1262- 3636(07)70008-3 12629449
27. Nair S, Mishra V, Hayden K, Lisboa PJ, Pandya B, Vinjamuri S, Hardy KJ, Wilding JP, The four-variable modification of diet in renal disease formula underestimates glomerular filtration rate in obese type 2 diabetic individuals with chronic kidney disease Diabetologia 2011
28. Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates. Al-Maskari F, El-Sadig M, Obineche E, BMC Nephrol. 2008 9 1 10.1186/1471-2369-9-1 18230135
29. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Thomas MC, MacIsaac RJ, Jerums G, Weekes A, Moran J, Shaw JE, et al. Diabetes Care 2009 32 1497 1502 10.2337/dc08-2186 19470839
30. Renal Insufficiency And Cardiovascular Events (RIACE) Study Group. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. Penno G, Solini A, Bonora E, Fondelli C, Orsi E, Zerbini G, Trevisan R, Vedovato M, Gruden G, Cavalot F, Cignarelli M, Laviola L, Morano S, Nicolucci A, Pugliese G, J Hypertens. 2011 29 1802 9 10.1097/HJH.0b013e3283495cd6 21738053
31. C, Barcelò MA and Saez M. Gender, socio-economic variables and target organ damage in new-diagnosed hypertensive patients. De Tuero G, Blood Pressure 2009 18 213 2 10.1080/08037050903145923 19591005
32. T anaka T. Saitoh M, Nishimura H, Kondoh T. Gender-related differences in target organ damage in untreated patients with essential hypertension. Intern Med. 2006 45 377 383
33. Diabetic nephropathy in the Arab Gulf Countries. Farag YMK, Al Wakeel JS, Nephron Clin Prac 2011 119 317 323 10.1159/000328909
34. Estimation of glomerular filtration rate in diabetic subjects Cockcroft formula or Modification of Diet in Renal Disease study equation? Rigalleau V, Lasseur C, Perlemoine C, Barthe N, Raffaitin C, Liu C, et al. Diabetes Care 2005 28 838 43 10.2337/diacare.28.4.838 15793182
35. Comparison of estimated glomerular filtration rates and albuminuria in predicting risk of coronary heart disease in a population with high prevalence of diabetes mellitus and renal disease. Shara NM, Wang H, Valaitis E, Pehlivanova M, Carter EA, Resnick H, et al. Am J Cardiol. 2011 107 399 405 10.1016/j.amjcard.2010.09.036 21257005
36. CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study. Weiner DE, Krassilnikova M, Tighiouart H, Salem DN, Levey AS, Sarnak MJ, BMC Nephrol. 2009 10 26 10.1186/1471-2369-10-26 19761597
37. Comparison between the enzymatic vitro assay for creatinine determination and three other methods adapted on the Olympus analyzer. Badiou S, Dupuy AM, Descamps B, Cristolead JP, J Clin Lab Anal 2003 17 235 4 10.1002/jcla.10103 14614747